# Safety of Imovax Polio in Chinese Infants and Children

> **NCT00258843** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 40 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Inactivated Poliomyelitis vaccine
- **BIOLOGICAL:** Inactivated Poliomyelitis vaccine

## Key facts

- **NCT ID:** NCT00258843
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-02
- **Final completion:** 2006-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00258843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00258843, "Safety of Imovax Polio in Chinese Infants and Children". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00258843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*